U
Navidea Biopharmaceuticals, Inc. NAVB
$0.0001 $0.000.00%
Recommendation
--
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

09/30/2023 06/30/2023 03/31/2023 12/31/2022 09/30/2022
Net Income -- 6.03M -1.48M -3.48M -5.71M
Total Depreciation and Amortization -- 27.10K 27.60K 26.50K 24.70K
Total Amortization of Deferred Charges -- 105.20K 92.20K 80.70K 70.70K
Total Other Non-Cash Items -- 161.70K -1.15M 241.00K 104.90K
Change in Net Operating Assets -- -1.64M 779.50K 701.30K 3.65M
Cash from Operations -- 4.69M -1.72M -2.43M -1.86M
Capital Expenditure -- 0.00 -15.10K 0.00 -14.40K
Sale of Property, Plant, and Equipment -- 300.00 -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -65.30K -24.30K -72.00K -64.50K
Cash from Investing -- -65.00K -39.40K -72.00K -78.90K
Total Debt Issued -- 300.00K -- 0.00 1.00M
Total Debt Repaid -- -504.50K -200.50K -64.70K 0.00
Issuance of Common Stock -- 643.80K -- 0.00 --
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- 1.10M -- 0.00 6.17M
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -54.60K -- -35.10K -963.30K
Cash from Financing -- 1.48M -200.50K -99.80K 6.21M
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -- 6.11M -1.96M -2.60M 4.27M
Weiss Ratings